Peter Kuhn of the USC Michelson Center for Convergent Bioscience will serve as deputy director of a new virtual cancer center, funded by a grant from the Department of Defense. (April 28, 2021)

Dedicated space for the Convergent Science Institute in Cancer initiative aims to get experts in physics, chemistry and biology to collaborate on cutting-edge science that benefits patients. (February 5, 2021)

A USC-led team has developed advanced imaging techniques that allow for a uniquely detailed glimpse inside the body’s insulin factories. (December 9, 2020)

Epic Sciences, Inc. announced an exclusive license and collaboration agreement with Dr. Peter Kuhn and the USC Michelson Center for Convergent Bioscience. (November 19, 2020)

Inspired by his father’s fight against non-Hodgkin’s lymphoma, Remo Rohs leads USC’s efforts in studying the molecular nature of cancer. (August 18, 2020)

Researchers have found what appears to be the likely order in which COVID-19 symptoms first appear: fever, cough and muscle pain, then nausea and/or vomiting, then diarrhea. (August 13, 2020)

The university’s COVID-19 Research Task Force brings together experts and hopes to speed the development of targeted treatments and accelerate their understanding of the disease. (July 9, 2020)

Scientists figured out how Gamma-aminobutyric acid, or GABA, interacts with a key protein receptor called GABAB. The study paints a clear picture of how GABA changes the shape of the GABAB protein and reveals a clear target site for new drugs. (June 17, 2020)

The Society for Research on Biological Rhythms (SRBR) honored Steve Kay with the 2020 Director’s Award in Research. (June 4, 2020)

The current way to make a highly targeted type of drug called “antibody-drug conjugates” is lengthy and inefficient. Scientists at the USC School of Pharmacy have engineered something better. (June 3, 2020)